N/A
Completed N=120
App-based Remote Blood Pressure Monitoring
Hypertension · Preeclampsia · Chronic Hypertension Complicating Pregnancy
Source: ClinicalTrials.gov NCT05595629 ↗
Enrolled (actual)
120
Serious AEs
0.0%
Results posted
Feb 2025
Primary outcomePrimary: Blood Pressure Ascertainment — 40; 39 Participants
Summary
Remote postpartum blood pressure monitoring program with text messages has been shown to increase adherence to recommended postpartum blood pressure checks among those with hypertension at discharge from birth hospitalization, but these programs require medically trained professionals to respond to each individual text message. A bluetooth-enabled blood pressure cuff that synchs automatically a smartphone application that leverages Artificial Intelligence to provide tailored recommendations based on recorded blood pressure measurements--and can also provide on-demand education on hypertension--may be less costly way to provide similar support.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Blood Pressure Ascertainment |
40; 39 | — |
| SECONDARY Postpartum Readmission for Hypertension or Preeclampsia |
4; 8 | — |
| SECONDARY Adherence to Evidence-based Practice |
15; 16 | — |
| SECONDARY Postpartum Severe Maternal Morbidity Composite |
0; 0 | — |
| SECONDARY "Using Any Number From 0 to 10 Where 0 is the Worst Possible Experience and 10 is the Best Possible Experience, Please Rate Your Experience in the Postpartum Hypertension Program" |
10; 10 | — |
| SECONDARY Decisional Regret Scale |
5; 0 | — |
Eligibility Criteria
Inclusion Criteria
- a) English- or Spanish-speaking
- b) maternal age >18 years old
- c) smartphone ownership for remote blood pressure ascertainment
- d) diagnosis of gestational hypertension, preeclampsia, or chronic hypertension at hospital discharge
- e) plan to receive postpartum care at a Women & Infants Hospital (WIH)-affiliated clinic
Exclusion Criteria
- a) fetal anomaly
- b) prisoners
- c) lack of smartphone
- d) inability to consent.
Data sourced from ClinicalTrials.gov (NCT05595629). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.